MARIA ANGELES AGUIRRE ZAMORANOCARLOS PÉREZ SÁNCHEZ2026-01-292026-01-29201510.1016/j.intimp.2015.06.0062-s2.0-84937162679https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26240ImmunologyImmunology and AllergyPharmacologyImmunologyImmunology and AllergyPharmacologyImmunotherapy in antiphospholipid syndromeresearch article